Related Experiment Video
Updated: Jul 26, 2025

Quail Chorioallantoic Membrane - A Tool for Photodynamic Diagnosis and Therapy
Published on: April 28, 2022
TELANGIECTATIC CAPILLARIES CAUSING PERSISTENT DIABETIC MACULAR EDEMA SUCCESSFULLY TREATED BY PHOTODYNAMIC THERAPY
Marion Schaeffer1, Léa Dormegny, Claude Speeg-Schatz
1Department of Ophthalmology, Nouvel Hôpital Civil, University of Strasbourg, Strasbourg, France.
Photodynamic therapy (PDT) effectively treated persistent diabetic macular edema caused by diabetic telangiectatic capillaries (TelCaps) when conventional laser therapy was not an option. This treatment restored visual acuity and reduced macular thickness in two patients.
Area of Science:
- Ophthalmology
- Diabetic Retinopathy Research
Background:
- Persistent macular edema is a common complication of diabetic retinopathy.
- Diabetic telangiectatic capillaries (TelCaps) can cause recalcitrant macular edema.
- Conventional treatments may be contraindicated or ineffective for certain cases of diabetic macular edema.
Purpose of the Study:
- To present two cases of persistent macular edema due to exudative TelCaps.
- To demonstrate the successful application of photodynamic therapy (PDT) in these cases.
Main Methods:
- Retrospective review of two patients with persistent macular edema caused by parafoveolar TelCaps.
- Photodynamic therapy (PDT) applied focally to perifoveolar TelCaps.
- Conventional laser therapy was not feasible due to TelCap proximity to the foveal center.
Main Results:
- Focal PDT successfully reduced persistent macular edema.
- Visual acuity was fully restored within 4-6 months post-PDT.
- Central macular thickness normalized in one case and significantly reduced in the other.
- Sustained visual gain was observed throughout the follow-up periods (2 years and 1 year).
Conclusions:
- Photodynamic therapy (PDT) is a viable treatment option for diabetic macular edema caused by TelCaps.
- PDT is particularly useful for cases unresponsive to intravitreal therapies or where conventional laser is contraindicated.
More Related Videos
11:04An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
Published on: January 13, 2023
05:00Intense Pulsed Light for the Treatment of Dry Eye Owing to Meibomian Gland Dysfunction
Published on: April 1, 2019